Gilder Gagnon Howe & Co’s Athenahealth, Inc. ATHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-601
| Closed | -$79K | – | 295 |
|
|
2018
Q4 | $79K | Sell |
601
-2,034
| -77% | -$261K | ﹤0.01% | 253 |
|
|
2018
Q3 | $352K | Sell |
2,635
-125
| -5% | -$18.7K | ﹤0.01% | 249 |
|
|
2018
Q2 | $439K | Sell |
2,760
-22
| -0.8% | -$3.26K | ﹤0.01% | 239 |
|
|
2018
Q1 | $398K | Sell |
2,782
-1
| -0% | -$137 | ﹤0.01% | 250 |
|
|
2017
Q4 | $370K | Sell |
2,783
-34
| -1% | -$4.34K | 0.01% | 248 |
|
|
2017
Q3 | $350K | Hold |
2,817
| – | – | ﹤0.01% | 232 |
|
|
2017
Q2 | $396K | Sell |
2,817
-8,053
| -74% | -$1.01M | 0.01% | 227 |
|
|
2017
Q1 | $1.23M | Sell |
10,870
-1,063
| -9% | -$124K | 0.02% | 189 |
|
|
2016
Q4 | $1.25M | Sell |
11,933
-3,447
| -22% | -$371K | 0.02% | 174 |
|
|
2016
Q3 | $1.94M | Sell |
15,380
-92
| -0.6% | -$11.7K | 0.03% | 171 |
|
|
2016
Q2 | $2.13M | Sell |
15,472
-77
| -0.5% | -$10.2K | 0.04% | 159 |
|
|
2016
Q1 | $2.16M | Buy |
15,549
+357
| +2% | +$49K | 0.04% | 147 |
|
|
2015
Q4 | $2.44M | Buy |
15,192
+12,091
| +390% | +$1.87M | 0.04% | 154 |
|
|
2015
Q3 | $414K | Sell |
3,101
-3
| -0.1% | -$391 | 0.01% | 213 |
|
|
2015
Q2 | $356K | Sell |
3,104
-27,637
| -90% | -$3.3M | ﹤0.01% | 239 |
|
|
2015
Q1 | $3.67M | Sell |
30,741
-1,929
| -6% | -$257K | 0.05% | 153 |
|
|
2014
Q4 | $4.76M | Sell |
32,670
-6,120
| -16% | -$768K | 0.07% | 148 |
|
|
2014
Q3 | $5.11M | Buy |
38,790
+259
| +0.7% | +$34.1K | 0.07% | 142 |
|
|
2014
Q2 | $4.82M | Buy |
38,531
+8,718
| +29% | +$1.13M | 0.06% | 167 |
|
|
2014
Q1 | $4.78M | Buy |
29,813
+4,559
| +18% | +$750K | 0.07% | 160 |
|
|
2013
Q4 | $3.4M | Sell |
25,254
-227
| -0.9% | -$29.2K | 0.05% | 169 |
|
|
2013
Q3 | $2.77M | Sell |
25,481
-179
| -0.7% | -$19.4K | 0.04% | 176 |
|
|
2013
Q2 | $2.17M | Buy |
+25,660
| New | +$2.3M | 0.04% | 186 |
|
Gilder Gagnon Howe & Co's ATHN Position: Q1 2019 in Review
Gilder Gagnon Howe & Co sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 601 shares — an estimated $79K sold.
Gilder Gagnon Howe & Co first reported a position in ATHN in Q2 2013 and held it in 23 quarters. The position peaked at $5.11M in Q3 2014. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.
- Gilder Gagnon Howe & Co reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
- Gilder Gagnon Howe & Co sold 601 Athenahealth, Inc. shares in Q1 2019, an estimated $79K.
- Gilder Gagnon Howe & Co first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 23 quarters.
- Gilder Gagnon Howe & Co's Athenahealth, Inc. position peaked at $5.11M in Q3 2014.
- 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.
Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2019, filed 17 May 2019.